TrialBreast cancer research and treatment2020

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.

Yvonne Brandberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.